Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pia Osterlund

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Journal of Clinical Medicine|May 27, 2023
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)Kaisa Lehtomäki, Leena-Maija Soveri, Emerik Osterlund, et al.
Acta Oncologica (Stockholm, Sweden)|February 3, 2026
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO StudyJoel Kontiainen, Kaisa Lehtomäki, Timo Muhonen, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?Denis Horgan, Anne-Marie Baird, Mark Middleton, et al.
Frontiers in Oncology|March 7, 2022
<i>KRAS</i>-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal CancerEmerik Osterlund, Ari Ristimäki, Soili Kytölä, et al.
Cancers|April 12, 2022
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-StudyKaisa Lehtomäki, Hanna P Stedt, Emerik Osterlund, et al.
Scientific Reports|July 2, 2025
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patientsAparna Ganesan, Anttoni Korkiakoski, Simona Adamusová, et al.
The British Journal of Surgery|December 13, 2022
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective studyAki Uutela, Arno Nordin, Emerik Osterlund, et al.
British Journal of Cancer|May 24, 2022
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO studyAki Uutela, Emerik Osterlund, Päivi Halonen, et al.
Cancers|March 13, 2024
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)Sonja Aho, Emerik Osterlund, Ari Ristimäki, et al.
International Journal of Cancer|September 19, 2023
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohortsEmerik Osterlund, Ari Ristimäki, Markus J Mäkinen, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Journal of Clinical Medicine|May 27, 2023
Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)Kaisa Lehtomäki, Leena-Maija Soveri, Emerik Osterlund, et al.
Acta Oncologica (Stockholm, Sweden)|February 3, 2026
Cost-effectiveness analysis of operative versus non-operative management of colorectal cancer metastases in the Finnish RAXO StudyJoel Kontiainen, Kaisa Lehtomäki, Timo Muhonen, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
How Can the EU Beating Cancer Plan Help in Tackling Lung Cancer, Colorectal Cancer, Breast Cancer and Melanoma?Denis Horgan, Anne-Marie Baird, Mark Middleton, et al.
Frontiers in Oncology|March 7, 2022
<i>KRAS</i>-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal CancerEmerik Osterlund, Ari Ristimäki, Soili Kytölä, et al.
Cancers|April 12, 2022
Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-StudyKaisa Lehtomäki, Hanna P Stedt, Emerik Osterlund, et al.
Scientific Reports|July 2, 2025
Evaluation of Bridge Capture technology for mutation profiling in liquid biopsies of metastatic colorectal cancer patientsAparna Ganesan, Anttoni Korkiakoski, Simona Adamusová, et al.
The British Journal of Surgery|December 13, 2022
Resectability and resection rates of colorectal liver metastases according to RAS and BRAF mutational status: prospective studyAki Uutela, Arno Nordin, Emerik Osterlund, et al.
British Journal of Cancer|May 24, 2022
Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO studyAki Uutela, Emerik Osterlund, Päivi Halonen, et al.
Cancers|March 13, 2024
Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)Sonja Aho, Emerik Osterlund, Ari Ristimäki, et al.
International Journal of Cancer|September 19, 2023
Atypical (non-V600E) BRAF mutations in metastatic colorectal cancer in population and real-world cohortsEmerik Osterlund, Ari Ristimäki, Markus J Mäkinen, et al.
Pageof 5